These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4206185)

  • 1. U.S. Food and Drug Administration requirements for toxicity testing of contraceptive products.
    Berliner VR
    Acta Endocrinol Suppl (Copenh); 1974; 185():240-65. PubMed ID: 4206185
    [No Abstract]   [Full Text] [Related]  

  • 2. Special problems in toxicity testing of long acting depot contraceptives.
    Neumann F; Berswordt-Wallrabe R VO; Elger W; Gräf KJ; Hasan SH; Mehring M; Nishino Y; Steinbeck H
    Acta Endocrinol Suppl (Copenh); 1974; 185():315-54. PubMed ID: 4206188
    [No Abstract]   [Full Text] [Related]  

  • 3. Mammary nodules in beagle dogs administered investigational oral contraceptive steroids.
    Giles RC; Kwapien RP; Geil RG; Casey HW
    J Natl Cancer Inst; 1978 Jun; 60(6):1351-64. PubMed ID: 650701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary carcinogenesis in female and male mice receiving contraceptives or gestagens.
    Rudali G; Coezy E; Chemama R
    J Natl Cancer Inst; 1972 Sep; 49(3):813-9. PubMed ID: 4119120
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA studies of estrogen, progestogens, and estrogen/progestogen combinations in the dog and monkey.
    Geil RG; Lamar JK
    J Toxicol Environ Health; 1977 Sep; 3(1-2):179-93. PubMed ID: 411941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant mammary tumors in beagle dogs dosed with investigational oral contraceptive steroids.
    Kwapien RP; Giles RC; Geil RG; Casey HW
    J Natl Cancer Inst; 1980 Jul; 65(1):137-44. PubMed ID: 6930510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Special requirements for testing post-coital contraceptives.
    Lerner LJ
    Acta Endocrinol Suppl (Copenh); 1974; 185():355-72. PubMed ID: 4206189
    [No Abstract]   [Full Text] [Related]  

  • 8. Special requirements for toxicity testing of oral compounds administered continuously or cyclically.
    Overbeek GA; Hornstra HW; van Julsingha EB; Mumford JP; Zayed I
    Acta Endocrinol Suppl (Copenh); 1974; 185():387-408. PubMed ID: 4206191
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative studies of the ethynyl estrogens used in oral contraceptives. VI. Effects with and without progestational agents on carbohydrate metabolism in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; De La Pena A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Aug; 30(2):146-53. PubMed ID: 98357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptives and breast cancer: laboratory evidence.
    Shubik P
    IARC Sci Publ; 1985; (65):33-5. PubMed ID: 2417950
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the carcinogenic effects of estrogens, progestins and oral contraceptives on cervix, uterus and ovary of animals and man.
    Drill VA
    Arch Toxicol Suppl; 1979; (2):59-84. PubMed ID: 288371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the antifertility drug enovid in five strains of mice, with particular regard to carcinogenesis.
    Heston WE; Vlahakis G; Desmukes B
    J Natl Cancer Inst; 1973 Jul; 51(1):209-24. PubMed ID: 4352748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary neoplasia in animals: pathologic aspects and the effects of contraceptive steroids.
    Casey HW; Giles RC; Kwapien RP
    Recent Results Cancer Res; 1979; 66():129-60. PubMed ID: 107546
    [No Abstract]   [Full Text] [Related]  

  • 15. Basaloid adenomas of the mammary gland in beagle dogs administered investigational contraceptive steroids.
    Kwapien RP; Giles RC; Geil RG; Casey HW
    J Natl Cancer Inst; 1977 Sep; 59(3):933-9. PubMed ID: 894750
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of early clinical trials for new contraceptive methods.
    Mishell DR; Nash HA
    Acta Endocrinol Suppl (Copenh); 1974; 185():266-78. PubMed ID: 4206186
    [No Abstract]   [Full Text] [Related]  

  • 18. Hounding the pill.
    Med J Aust; 1979 Oct; 2(8):406-7. PubMed ID: 318466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teratogenic screening methods and their application to contraceptive products.
    Tuchmann-Duplessis H
    Acta Endocrinol Suppl (Copenh); 1974; 185():203-23. PubMed ID: 4206184
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of oral contraceptives on breast diseases.
    Fechner RE
    Cancer; 1977 Jun; 39(6 Suppl):2764-71. PubMed ID: 406035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.